ID DH-3233:2020 Type Component Version 2.0 Status Active Created date 11/06/2020 Updated date 03/07/2020 This version has been superseded: see other versions below. This release of the end product EP-3221:2020 aligns all Electronic Prescribing Conformance Test Specifications and Conformance Test Data with the Electronic Prescribing Participating Software Conformance Profile v2.2 . Download Conformance Test Specification - Release Note v2.0 DH_3233_2020_ElectronicPrescribing_ConformanceTestSpecification-ReleaseNote_v2.0.pdf () Checksum: 8411ce5128c5763b8e754e78045e481242bb2f369a9aed78c45f2158531453b4 This component belongs to the following product: Electronic Prescribing - Conformance Test Specifications v2.0 - superseded Subsequent versions Electronic Prescribing - Conformance Test Specification Documents Release Note v3.0.6 - current Electronic Prescribing - Conformance Test Specifications - Release Note v3.0.5 - superseded Electronic Prescribing - Conformance Test Specifications - Release Note v3.0.4 - superseded Electronic Prescribing - Conformance Test Specifications - Release Note v3.0.3 - superseded Electronic Prescribing - Conformance Test Specifications - Release Note v3.0.2 - superseded Electronic Prescribing - Conformance Test Specifications - Release Note v3.0.1 - superseded Electronic Prescribing - Conformance Test Specifications - Release Note v3.0 - superseded Electronic Prescribing - Conformance Test Specifications – Release Note v2.3 - superseded Electronic Prescribing - Conformance Test Specifications – Release Note v2.2 - superseded Electronic Prescribing - Conformance Test Specifications – Release Note v2.1 - superseded